ANELLOVECTOR Trademark

Trademark Overview


On Friday, August 4, 2023, a trademark application was filed for ANELLOVECTOR with the United States Patent and Trademark Office. The USPTO has given the ANELLOVECTOR trademark a serial number of 98118232. The federal status of this trademark filing is REGISTERED as of Tuesday, August 6, 2024. This trademark is owned by Ring Therapeutics, Inc.. The ANELLOVECTOR trademark is filed in the Pharmaceutical Products category with the following description:

Encapsulated nucleic acid agents for medical use; pharmaceutical preparations for use in the prevention, diagnosis and treatment of disease, namely, rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune/autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in gene therapy
anellovector

General Information


Serial Number98118232
Word MarkANELLOVECTOR
Filing DateFriday, August 4, 2023
Status700 - REGISTERED
Status DateTuesday, August 6, 2024
Registration Number7469817
Registration DateTuesday, August 6, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 2, 2024

Trademark Statements


Goods and ServicesEncapsulated nucleic acid agents for medical use; pharmaceutical preparations for use in the prevention, diagnosis and treatment of disease, namely, rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune/autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in gene therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 11, 2023
Primary Code005
First Use Anywhere DateWednesday, October 11, 2023
First Use In Commerce DateWednesday, October 11, 2023

Trademark Owner History


Party NameRing Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141

Party NameRing Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141

Party NameRing Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141

Trademark Events


Event DateEvent Description
Tuesday, August 8, 2023NEW APPLICATION ENTERED
Wednesday, November 29, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 11, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 28, 2023ASSIGNED TO EXAMINER
Tuesday, December 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 26, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, December 13, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 7, 2024USE AMENDMENT FILED
Tuesday, January 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 27, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 3, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, July 3, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 6, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, August 6, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, March 7, 2024TEAS STATEMENT OF USE RECEIVED
Friday, March 29, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 29, 2024STATEMENT OF USE PROCESSING COMPLETE